Package 51662-1242-3

Brand: naloxone hci

Generic: naloxone hci
NDC Package

Package Facts

Identity

Package NDC 51662-1242-3
Digits Only 5166212423
Product NDC 51662-1242
Product ID 51662-1242_0ff862db-44cb-aac2-e063-6394a90a8a5d
Description

50 POUCH in 1 CASE (51662-1242-3) / 1 mL in 1 POUCH (51662-1242-2)

Marketing

Marketing Status
Marketed Since 2020-06-15
Brand naloxone hci
Generic naloxone hci
Sample Package No

Linked Drug Pages (1)

NALOXONE HCI ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAMUSCULAR", "INTRAVENOUS", "SUBCUTANEOUS"], "spl_id": "0ff862db-44cb-aac2-e063-6394a90a8a5d", "openfda": {"unii": ["F850569PQR"], "rxcui": ["1659929"], "spl_set_id": ["73c1bad3-6ac3-8682-e053-2a91aa0a176a"], "manufacturer_name": ["HF Acquisition Co. LLC, DBA Health First"]}, "finished": true, "packaging": [{"sample": false, "description": "1 mL in 1 VIAL (51662-1242-1)", "package_ndc": "51662-1242-1", "marketing_start_date": "20180818"}, {"sample": false, "description": "50 POUCH in 1 CASE (51662-1242-3)  / 1 mL in 1 POUCH (51662-1242-2)", "package_ndc": "51662-1242-3", "marketing_start_date": "20200615"}], "brand_name": "NALOXONE HCI", "product_id": "51662-1242_0ff862db-44cb-aac2-e063-6394a90a8a5d", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Opioid Antagonist [EPC]", "Opioid Antagonists [MoA]"], "product_ndc": "51662-1242", "generic_name": "NALOXONE HCI", "labeler_name": "HF Acquisition Co. LLC, DBA Health First", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "NALOXONE HCI", "active_ingredients": [{"name": "NALOXONE HYDROCHLORIDE", "strength": ".4 mg/mL"}], "application_number": "ANDA070256", "marketing_category": "ANDA", "marketing_start_date": "20180818", "listing_expiration_date": "20261231"}